APTO
Price
$0.18
Change
-$0.01 (-5.26%)
Updated
Dec 18 closing price
LCTX
Price
$0.50
Change
-$0.00 (-0.00%)
Updated
Dec 18 closing price
77 days until earnings call
Ad is loading...

APTO vs LCTX

Header iconAPTO vs LCTX Comparison
Open Charts APTO vs LCTXBanner chart's image
Aptose Biosciences
Price$0.18
Change-$0.01 (-5.26%)
Volume$531.98K
CapitalizationN/A
Lineage Cell Therapeutics
Price$0.50
Change-$0.00 (-0.00%)
Volume$1.83M
CapitalizationN/A
APTO vs LCTX Comparison Chart
Loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTO vs. LCTX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTO is a Hold and LCTX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (APTO: $0.18 vs. LCTX: $0.50)
Brand notoriety: APTO and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTO: 83% vs. LCTX: 87%
Market capitalization -- APTO: $11.02M vs. LCTX: $110.54M
APTO [@Biotechnology] is valued at $11.02M. LCTX’s [@Biotechnology] market capitalization is $110.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTO’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • APTO’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, LCTX is a better buy in the long-term than APTO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTO’s TA Score shows that 6 TA indicator(s) are bullish while LCTX’s TA Score has 5 bullish TA indicator(s).

  • APTO’s TA Score: 6 bullish, 4 bearish.
  • LCTX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APTO is a better buy in the short-term than LCTX.

Price Growth

APTO (@Biotechnology) experienced а -2.77% price change this week, while LCTX (@Biotechnology) price change was -18.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.12%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was -1.61%.

Reported Earning Dates

APTO is expected to report earnings on Aug 10, 2023.

LCTX is expected to report earnings on Mar 06, 2025.

Industries' Descriptions

@Biotechnology (-7.12% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LCTX($111M) has a higher market cap than APTO($11M). LCTX YTD gains are higher at: -53.991 vs. APTO (-92.961). APTO has less debt than LCTX: APTO (919K) vs LCTX (3.25M).
APTOLCTXAPTO / LCTX
Capitalization11M111M10%
EBITDAN/AN/A-
Gain YTD-92.961-53.991172%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total Cash2.9MN/A-
Total Debt919K3.25M28%
FUNDAMENTALS RATINGS
APTO vs LCTX: Fundamental Ratings
APTO
LCTX
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
38
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10097
PRICE GROWTH RATING
1..100
9795
P/E GROWTH RATING
1..100
10066
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LCTX's Valuation (38) in the null industry is somewhat better than the same rating for APTO (90) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than APTO’s over the last 12 months.

LCTX's Profit vs Risk Rating (100) in the null industry is in the same range as APTO (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to APTO’s over the last 12 months.

LCTX's SMR Rating (97) in the null industry is in the same range as APTO (100) in the Biotechnology industry. This means that LCTX’s stock grew similarly to APTO’s over the last 12 months.

LCTX's Price Growth Rating (95) in the null industry is in the same range as APTO (97) in the Biotechnology industry. This means that LCTX’s stock grew similarly to APTO’s over the last 12 months.

LCTX's P/E Growth Rating (66) in the null industry is somewhat better than the same rating for APTO (100) in the Biotechnology industry. This means that LCTX’s stock grew somewhat faster than APTO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APTOLCTX
RSI
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
79%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
APTO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LCTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL248.05-5.43
-2.14%
Apple
SPY586.28-18.01
-2.98%
SPDR® S&P 500® ETF Trust
BTC.X100041.540000-6099.062500
-5.75%
Bitcoin cryptocurrency
TSLA440.13-39.73
-8.28%
Tesla
GME28.55-2.71
-8.67%
GameStop Corp

APTO and

Correlation & Price change

A.I.dvisor tells us that APTO and LCTX have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTO and LCTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTO
1D Price
Change %
APTO100%
-4.69%
LCTX - APTO
31%
Poorly correlated
+0.93%
ORMP - APTO
25%
Poorly correlated
+2.13%
ORIC - APTO
24%
Poorly correlated
-6.91%
INBX - APTO
23%
Poorly correlated
-3.16%
BNOX - APTO
23%
Poorly correlated
-4.03%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with GBIO. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then GBIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+0.93%
GBIO - LCTX
33%
Loosely correlated
-6.42%
MGTX - LCTX
32%
Poorly correlated
-8.75%
ABSI - LCTX
31%
Poorly correlated
-8.71%
APTO - LCTX
31%
Poorly correlated
-4.69%
NTLA - LCTX
30%
Poorly correlated
-8.45%
More